Cited by 68Pneumocystis jirovecii pneumonia detection and treatmentFungal Plant Pathogen ControlAntifungal resistance and susceptibility

Recapitulation in Saccharomyces cerevisiae of Cytochrome b Mutations Conferring Resistance to Atovaquone in Pneumocystis jiroveci

Open access
Hill, Philip, Kessl, Jacques, Fisher, Nicholas, Meshnick, Steven, Trumpower, Bernard L., Meunier, Brigitte·2003·Antimicrobial Agents and Chemotherapy

Abstract

Pneumocystis jiroveci (human-derived P. carinii ) is an opportunistic pathogenic fungus which causes pneumonia and is life-threatening in immunocompromised individuals. Spontaneously acquired resistance to atovaquone, a hydroxynaphthoquinone that is used to treat P. jiroveci infections, was linked to mutations in the mitochondrially encoded cytochrome b gene. Because P. jiroveci cannot be easily cultivated, we have developed Saccharomyces cerevisiae as an alternative system to study atovaquone resistance mutations. In this work, we introduced seven mutations linked with atovaquone resistance in P. jiroveci into the S. cerevisiae cytochrome b gene. The effects of the mutations on the respiratory function and on the sensitivity to the inhibitor were then characterized. Six of the reported mutations lowered the sensitivity of the S. cerevisiae bc 1 complex to atovaquone, while one mutation had no effect on the drug resistance. These results were confirmed by monitoring the in vivo resistance of S. cerevisiae mutants which carried both the cytochrome b mutations and a deletion of the ABC transporter genes, allowing the drug to bypass the weakened efflux pump system. S. cerevisiae thus provides an easy-to-use system to characterize in vivo and in vitro cytochrome b mutations reported in pathogens and to assess their role in drug resistance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.47.9.2725-2731.2003

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hill, P., Kessl, J., Fisher, N., Meshnick, S., Trumpower, B. L., & Meunier, B.
Affiliations
  • University College London (GB)
  • Dartmouth College (US)
  • University of North Carolina at Chapel Hill (US)
Corresponding author
  • Trumpower, Bernard L.
  • Meunier, Brigitte
Venue
Antimicrobial Agents and Chemotherapy
Published
2003-09
Volume
47
Issue
9
Pages
2725-2731
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2133852460
Cited by
68
References
17
Citations by year
2026: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 6 · 2013: 5 · 2012: 4
FWCI
3.04
Type
journal article
Language
en
Open access
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • Biotechnology and Biological Sciences Research Council
  • National Institute of General Medical Sciences (GM 20379, R37GM020379, R01GM020379)
  • National Institute of Allergy and Infectious Diseases (R01AI046966, AI46966)
Topics
  • Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Fungal Plant Pathogen Control
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
atovaquone resistance, Pneumocystis jirovecii, cytochrome b mutations, bc1 complex, Saccharomyces cerevisiae model, hydroxynaphthoquinones, electron transport chain, drug efflux, antifungal resistance, Pneumocystis carinii pneumonia
MeSH terms
Amino Acid Sequence, Antifungal Agents, Cytochrome b Group, Microbial Sensitivity Tests, Models, Molecular, Molecular Sequence Data, Mutation, Naphthoquinones, Oxygen Consumption, Pneumocystis, Protein Conformation, Saccharomyces cerevisiae, Mutagenesis, Site-Directed, Drug Resistance, Fungal, Atovaquone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review